Matthew M. Meyerson

Broad Institute

Public scientific profile · Unclaimed

Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.

Top expertise

Neuroendocrine Tumor Research Advances
Strong evidence · 1 supporting paper · latest 2026
Protein Degradation and Inhibitors
Solid evidence · 1 supporting paper · latest 2026
Histone Deacetylase Inhibitors Research
Supporting evidence · 1 supporting paper · latest 2026
PARP inhibition in cancer therapy
Supporting evidence · 1 supporting paper · latest 2026
Salivary Gland Tumors Diagnosis and Treatment
Supporting evidence · 1 supporting paper · latest 2026
Gastrointestinal Tumor Research and Treatment
Supporting evidence · 1 supporting paper · latest 2026

Spatial Transcriptomics Reveals Local Subtype-Specific Identity and Signaling within Multifocal Small Intestinal Neuroendocrine Tumors
2026DOI
Abstract 7064: Development of a new class of KAT6A/B inhibitors with in vivo efficacy.
2026DOI

Affiliation evidence only — not confirmed current employment.

Source: OpenAlex · retrieved 2026-09-29

Source: ScienceWe Extractor · retrieved 2026-09-27